Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. D Ribose
2. D-ribose
3. Ribose
1. 50-69-1
2. Aldehydo-d-ribose
3. Ribose, D-
4. Aldehydo-d-ribo-pentose
5. Ribo-2,3,4,5-tetrahydroxyvaleraldehyde, D-
6. 34466-20-1
7. D-ribose(mixture Of Isomers)
8. D-ribo-2,3,4,5-tetrahydroxyvaleraldehyde
9. 681hv46001
10. D(-)-ribose
11. Einecs 200-059-4
12. Brn 1723081
13. Dl-ribose
14. Unii-681hv46001
15. Riboxyl
16. D-ribose,(s)
17. D-ribose (open Form)
18. Ribose [inci]
19. D-ribose [fhfi]
20. Ribose [usp-rs]
21. D-ribose [mi]
22. D-ribose [who-dd]
23. Dsstox_cid_23917
24. Dsstox_gsid_43917
25. Schembl22679
26. 4-01-00-04211 (beilstein Handbook Reference)
27. D-(-)-ribose, 98%
28. Dtxsid6043917
29. Fema No. 3793
30. Chebi:47014
31. Fema 3793
32. D-(-)-ribose, >=98%
33. D-(-)-ribose, >=99%
34. Dtxsid101019160
35. Bcp04566
36. Tox21_303971
37. Ac7811
38. Mfcd06799032
39. S5544
40. Zinc18168713
41. Akos016842327
42. Bcp9000577
43. Ccg-266199
44. Cs-w019558
45. Db15073
46. Hy-w018772
47. Cas-50-69-1
48. Ncgc00357197-01
49. Bcp0726000059
50. Db-030333
51. Am20100223
52. D-(-)-ribose, For Synthesis, 97-102%
53. D-(-)-ribose, Vetec(tm) Reagent Grade, 99%
54. Wurcs=2.0/1,1,0/[o222h]/1/
55. A828251
56. (2r,3r,4r)-2,3,4,5-tetrahydroxypentanal;d-ribose
57. D-(-)-ribose, Plant Cell Culture Tested, Bioreagent
58. D-(-)-ribose, Suitable For Cell Culture, Bioreagent
59. Q27120759
60. D-(-)-ribose, >=99.0% (sum Of Enantiomers, Hplc)
61. E5431ed6-777d-48c4-ae76-2b114fabe2d6
62. Ribose, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 150.13 g/mol |
|---|---|
| Molecular Formula | C5H10O5 |
| XLogP3 | -2.3 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 150.05282342 g/mol |
| Monoisotopic Mass | 150.05282342 g/mol |
| Topological Polar Surface Area | 98 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 104 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Ribose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ribose manufacturer or Ribose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ribose manufacturer or Ribose supplier.
PharmaCompass also assists you with knowing the Ribose API Price utilized in the formulation of products. Ribose API Price is not always fixed or binding as the Ribose Price is obtained through a variety of data sources. The Ribose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A D-Ribose(mixture of isomers) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D-Ribose(mixture of isomers), including repackagers and relabelers. The FDA regulates D-Ribose(mixture of isomers) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D-Ribose(mixture of isomers) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of D-Ribose(mixture of isomers) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A D-Ribose(mixture of isomers) supplier is an individual or a company that provides D-Ribose(mixture of isomers) active pharmaceutical ingredient (API) or D-Ribose(mixture of isomers) finished formulations upon request. The D-Ribose(mixture of isomers) suppliers may include D-Ribose(mixture of isomers) API manufacturers, exporters, distributors and traders.
click here to find a list of D-Ribose(mixture of isomers) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A D-Ribose(mixture of isomers) DMF (Drug Master File) is a document detailing the whole manufacturing process of D-Ribose(mixture of isomers) active pharmaceutical ingredient (API) in detail. Different forms of D-Ribose(mixture of isomers) DMFs exist exist since differing nations have different regulations, such as D-Ribose(mixture of isomers) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A D-Ribose(mixture of isomers) DMF submitted to regulatory agencies in the US is known as a USDMF. D-Ribose(mixture of isomers) USDMF includes data on D-Ribose(mixture of isomers)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The D-Ribose(mixture of isomers) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of D-Ribose(mixture of isomers) suppliers with USDMF on PharmaCompass.
D-Ribose(mixture of isomers) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D-Ribose(mixture of isomers) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D-Ribose(mixture of isomers) GMP manufacturer or D-Ribose(mixture of isomers) GMP API supplier for your needs.
A D-Ribose(mixture of isomers) CoA (Certificate of Analysis) is a formal document that attests to D-Ribose(mixture of isomers)'s compliance with D-Ribose(mixture of isomers) specifications and serves as a tool for batch-level quality control.
D-Ribose(mixture of isomers) CoA mostly includes findings from lab analyses of a specific batch. For each D-Ribose(mixture of isomers) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D-Ribose(mixture of isomers) may be tested according to a variety of international standards, such as European Pharmacopoeia (D-Ribose(mixture of isomers) EP), D-Ribose(mixture of isomers) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D-Ribose(mixture of isomers) USP).
